Dexmedetomidine Recruiting Phase 3 Trials for Dexmedetomidine (DB00633)

DBCOND0050052 (Dexmedetomidine)Recruiting3 IdentifierTitlePurposeDrugs
NCT05485519Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs.Treatment
NCT05335655IV Dexmedetomidine in the Duration of Spinal Anesthesia With Hyperbaric Bupivacaine: Double Blind Randomized Trial.Supportive Care
NCT05192629Intranasal Dexmedetomidine Versus Oral Midazolam as Premedication for Propofol Sedation in Pediatric Patients Undergoing Magnetic Resonance ImagingTreatment
NCT05158348A Comparative Study to Measure the Effect of Nebulized DexmedetomidineTreatment
NCT04144933Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal SurgeryPrevention